BCL2L13 and glioblastoma: An atypical member of the Bcl-2 family, known as Bcl2L13, is elevated in a number of cancers including GBM, and over-expression of this protein in an orthotopic xenograft mouse model of GBM is associated with disease progression and decreased survival [188].